Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) and what is the scope of patent protection?
Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
is the generic ingredient in nine branded drugs marketed by Lannett, Lilly, Forest Pharms, Wyeth Ayerst, Bristol Myers Squibb, Alpharma Us Pharms, Lederle, Impax Labs, Purepac Pharm, and Pal Pak, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.Summary for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
US Patents: | 0 |
Tradenames: | 9 |
Applicants: | 10 |
NDAs: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Patent Applications: | 161 |
DailyMed Link: | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
US Patents and Regulatory Information for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pal Pak | TRIPLE SULFOID | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) | TABLET;ORAL | 080094-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | SULFOSE | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) | TABLET;ORAL | 080013-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | TERFONYL | trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) | TABLET;ORAL | 006904-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |